Me yasa Ake Amfani da Maganin Ƙarƙashin Matattu Don allurar rigakafin COVID

SAUKI PHOTO: Wani ma'aikacin likita ya kama sirinji mai dauke da kashi na Pfizer-BioNTech COVID-19 a cibiyar rigakafin cutar Coronavirus (COVID-19) a Neuilly-sur-Seine, Faransa, Fabrairu 19, 2021. -Reuter

KUALA LUMpur, Feb 20: Malaysia za ta sami allurar COVID-19 Pfizer-BioNTech gobe (21 ga Fabrairu), kuma ana sa ran za a yi amfani da ƙananan matattun sirinji miliyan 12 don allurar, a ƙarƙashin kashi na farko na Shirin rigakafin COVID-19 na ƙasa.

Me yasa amfani da wannan nau'in sirinji yake da mahimmanci a cikin shirin, wanda zai fara ranar 26 ga Fabrairu, kuma menene mahimmancinsa da fa'idarsa idan aka kwatanta da sauran sirinji?

Shugaban Jami'ar Kebangsaan Malaysia Farfesa Dokta Mohd Makmor Bakry, ya ce sirinji yana da mafi ƙarancin 'hub' (mataccen sarari tsakanin allura da ganga na sirinji) wanda zai iya rage ɓarnawar rigakafin, idan aka kwatanta da sirinji na yau da kullun.

Ya ce ta haka ne za a iya kara yawan adadin adadin da za a iya samarwa daga kwalbar rigakafin yana mai cewa ga rigakafin COVID-19, ana iya samar da allurai guda shida da za a iya allura tare da yin amfani da sirinji.

Malamin kantin magani ya ce bisa ga matakan shirye-shirye na allurar Pfizer da aka bayar a gidan yanar gizon Cibiyar Kula da Cututtuka, kowane vial na rigakafin da aka diluted da 1.8ml na 0.9 bisa dari na sodium chloride zai iya ba da allurai biyar na allura.

"Mataccen girma shine adadin ruwan da ya rage a cikin sirinji da allura bayan allura.

"Don haka, idansirinji mai ƙarancin girmaana amfani da shi don maganin COVID-19 Pfizer-BioNTech, yana ba da damar kowane vial na rigakafi don samarwaallurai shida, "ya gaya wa Bernama lokacin da aka tuntube shi.

Da yake mai da wannan ra'ayi, shugaban kungiyar masana harhada magunguna ta Malaysia Amrahi Buang ya ce ba tare da yin amfani da sirinji na zamani ba, za a barnatar da jimillar 0.08 ml ga kowane kwano na maganin.

Ya ce, da yake allurar tana da kima da tsada a wannan lokaci, yin amfani da sirinji na da matukar muhimmanci wajen tabbatar da cewa ba a samu asara da asara ba.

"Idan kun yi amfani da sirinji na yau da kullum, a mahaɗin tsakanin sirinji da allura, za a sami 'mataccen sarari', wanda idan muka danna plunger, ba dukkanin maganin rigakafi ba ne zai fito daga sirinji ya shiga cikin mutum. jiki.

"Don haka idan kun yi amfani da sirinji tare da fasaha mai kyau, za a sami raguwar 'sararin da ya mutu'...dangane da gogewarmu, ƙarancin 'mataccen sararin samaniya' yana yin tanadin 0.08 ml na allurar rigakafi ga kowane vial," in ji shi.

Amrahi ya ce tunda sirinji ya kunshi amfani da fasaha mai inganci, farashin sirinji ya dan yi tsada fiye da na yau da kullun.

"Wannan sirinji yawanci ana amfani da shi don magunguna masu tsada ko alluran rigakafi don tabbatar da cewa babu ɓarna… don salin na yau da kullun, ba daidai ba ne a yi amfani da sirinji na yau da kullun kuma a rasa 0.08 ml amma ba akan maganin COVID-19 ba," in ji shi.

A halin da ake ciki, Dr Mohd Makmor ya ce ba kasafai ake amfani da sirinji mai karamin karfi ba, sai dai wasu kayan alluran da ake amfani da su kamar su magungunan kashe jini, insulin da sauransu.

"A lokaci guda, da yawa suna cike da riga-kafi ko kashi ɗaya (na allurar rigakafi) kuma a mafi yawan lokuta, za a yi amfani da sirinji na yau da kullun," in ji shi, ya kara da cewa akwai nau'ikan sirinji masu ƙarancin matattu guda biyu, wato Luer. kulle ko saka allura.

A ranar 17 ga watan Fabrairu, ministan kimiyya, fasaha da kirkire-kirkire Khairy Jamaluddin ya ce gwamnati ta samu adadin sirinji da ake bukata don rigakafin Pfzer-BioNTech.

An ruwaito Ministan Lafiya Datuk Seri Dr Adham Baba ya bayyana cewa ma’aikatar lafiya na bukatar allurar matattu miliyan 12 don yi wa kashi 20 cikin 100 ko miliyan shida allurar rigakafi a kashi na farko na shirin rigakafin cutar COVID-19 na kasa wanda za a fara daga baya. wata.

Ya ce nau’in sirinji na da matukar muhimmanci domin ana bukatar allurar rigakafin ta musamman ga kowane mutum domin tabbatar da ingancinsa.- Bernama


Lokacin aikawa: Fabrairu-10-2023